OTCM
BRCNF
Market cap11mUSD
Oct 19, Last price
0.92USD
1D
0.00%
1Q
-33.33%
Name
Burcon NutraScience Corp
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Burcon NutraScience Corporation, along with its associated entities, is a Canadian enterprise specializing in the development and commercialization of plant-derived proteins and functional ingredients for the food and beverage sectors. Its extensive product line features Peazazz, a versatile pea protein suitable for a range of applications including dairy alternatives, ready-to-drink and dry-blended beverages, snack bars, baked goods, and meat substitutes. Also derived from peas, Peazac and Peazac 850 are tailored for plant-based meat alternatives, ready-to-mix powders and drinks, dairy-free options, and nutritional bars, particularly valued for their neutral taste profile and moderate textural properties. Among its canola-based proteins is Puratein, an isolate frequently utilized in meat alternatives such as burgers and sausages, as well as nutrition bars. Supertein, a pale-hued canola protein powder, is incorporated into non-dairy frozen desserts, egg replacers, plant-based marshmallows, ready-to-mix beverages, whipped toppings, and plant-based snack bars. Additionally, Nutratein, a canola protein composed of globulin and albumin, finds utility in meat and egg alternatives, alongside various other functional plant-based foods. Further expanding its offerings are Nutratein-PS and Nutratein-TZ, custom blends featuring its Peazac pea protein, alongside CLARISOY, a soy protein employed across sports nutrition beverages, citrus and fruit-flavored drinks, lemonades, powdered beverage mixes, and diverse other food and dietary items. Finally, MeritPro stands as a unique nutritional protein blend, distinguished by being allergen-free, gluten-free, dairy-free, non-GMO, and vegan-friendly. Originally incorporated in 1998 as Burcon Capital Corp., the firm rebranded to Burcon NutraScience Corporation in October 1999. Its corporate headquarters are situated in Vancouver, Canada.
Key people
Peter Kappel
Independent Chairman of the Board · since 2023
Kip Underwood
Chief Executive Officer · since 2022
Randy Willardsen
Senior Vice President - Process · since 2001
Martin Schweizer
Vice President - Technical Development · since 2009
Senior Vice President - Legal, Corporate Secretary · since 2010
Philip Dowad
Director · since 2025
Richard Nazur
Director · since 2025
John Vassallo
Director · since 2024
Alan Chan
Independent Director · since 2023
Jeanne Mccaherty
Independent Director · since 2021
James Pekar
Independent Director · since 2024
Headquarters & legal address
BURRARD STREET 666
SUITE 1700, PARK PLACE
Vancouver, BC V6C 2X8
CA
SUITE 1700, PARK PLACE
Vancouver, BC V6C 2X8
CA
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||